InvestorsHub Logo

CherryTree1

08/27/21 9:00 AM

#398308 RE: learningcurve2020 #398303

WRONG Curve

The trial was over many years ago, IMO. Anything LL was alluding to yesterday would be for some subset of patients that might get accepted into future DC combo trials or Compassionate Use programs


LL is recommending people save their tumor tissue so they can use DCVAX when it is approved in the very near future because still blinded journal article data shows that it is a cure for 1 in every 3 or 4 patients and about half of the methylated.

Bacchus1

08/27/21 9:01 AM

#398309 RE: learningcurve2020 #398303

What a complete load of nonsense.

JRIII

08/27/21 9:57 AM

#398326 RE: learningcurve2020 #398303

This is almost entirely correct. The company gave up on this trial a long time ago. They have known it is a total failure for six years now, and they have kept playing games to drag things out as long as possible so they can keep paying themselves. And they have paid themselves very, very well. Their commitment to this Phase 3 trial is nothing beyond superficial words and going through the motions to make sure shareholders always believe something is coming, something is imminent, so stay tuned. It's all a lie. Since 2014, it's all been lies. How could any shareholder experience the broken promises of 2020, and the complete silence that followed, and not understand the scope of lies that constitute this entire operation? Dr. Liau disassociated herself from the company a long time ago, and is now committed to her own DCVax projects. She won't even mention Northwest Biotherapeutics or the CEO's name anymore. No love lost there. NWBO is a total failure, but they are going to drag this out until bitter end, until they are simply unable to get anyone else to give them money.